Carmustina Medac

Download summary of product characteristics:

Download SmPC

Malignant neoplasms in monotherapy or in combination with other antineoplastic agents and/or other therapeutic measures (radiation therapy, surgery):

  • Brain tumors (glioblastoma, brainstem gliomas, medulloblastoma, astrocytoma, and ependymoma), brain metastases.
  • Second-line treatment in non-Hodgkin lymphoma and Hodgkin’s disease.
  • Pre-transplant conditioning treatment for autologous hematopoietic progenitor cell transplantation (HPCT) in malignant hematologic disorders (Hodgkin’s disease/non-Hodgkin lymphoma).

Carmustina Obvius 100 mg powder and solvent for concentrate for solution for infusion, 1 vial and 1 ampoule.

Related products